id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-D-0023-0007,FDA,FDA-2005-D-0023,Guideline,Supporting & Related Material,GDL-Guidance,2006-10-10T04:00:00Z,2006,10,,,2008-04-11T23:46:19Z,,0,0,090000648043e7b8
FDA-2005-D-0023-0008,FDA,FDA-2005-D-0023,FDA,Notice,NAD-Notice of Availability of Data,2006-10-10T04:00:00Z,2006,10,2006-10-04T04:00:00Z,,2008-04-11T23:46:20Z,,0,0,090000648043e7b9
FDA-2005-D-0023-0005,FDA,FDA-2005-D-0023,Guidance,Supporting & Related Material,GDL-Guidance,2006-04-28T04:00:00Z,2006,4,,,2008-04-11T23:46:19Z,,0,0,090000648043e7b3
FDA-2005-D-0023-0006,FDA,FDA-2005-D-0023,FDA,Notice,NAD-Notice of Availability of Data,2006-04-28T04:00:00Z,2006,4,2006-04-26T04:00:00Z,2007-04-27T03:59:59Z,2008-04-11T23:46:19Z,,0,0,090000648043e7b4
FDA-2005-D-0023-0004,FDA,FDA-2005-D-0023,Number not used,Supporting & Related Material,FONS-Finding of no Significant Impact,2006-04-27T04:00:00Z,2006,4,,,2008-04-11T23:46:19Z,,0,0,090000648043e7b1
FDA-2005-D-0023-0003,FDA,FDA-2005-D-0023,Guidance,Supporting & Related Material,GDL-Guidance,2005-06-07T04:00:00Z,2005,6,,,2008-04-11T23:46:18Z,,0,0,090000648043e79c
FDA-2005-D-0023-0001,FDA,FDA-2005-D-0023,FDA,Notice,NAD-Notice of Availability of Data,2005-06-07T04:00:00Z,2005,6,2005-06-06T04:00:00Z,2005-08-09T03:59:59Z,2008-04-11T23:46:19Z,,0,0,090000648043e798
FDA-2005-D-0023-0002,FDA,FDA-2005-D-0023,Guidance,Supporting & Related Material,GDL-Guidance,2005-06-07T04:00:00Z,2005,6,,,2008-04-11T23:46:20Z,,0,0,090000648043e79b